chr2-99361767-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000289371.11(EIF5B):āc.866C>Gā(p.Thr289Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000393 in 1,579,392 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000289371.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF5B | NM_015904.4 | c.866C>G | p.Thr289Ser | missense_variant | 4/24 | ENST00000289371.11 | NP_056988.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF5B | ENST00000289371.11 | c.866C>G | p.Thr289Ser | missense_variant | 4/24 | 1 | NM_015904.4 | ENSP00000289371 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000422 AC: 9AN: 213472Hom.: 0 AF XY: 0.0000684 AC XY: 8AN XY: 116956
GnomAD4 exome AF: 0.0000378 AC: 54AN: 1427066Hom.: 0 Cov.: 31 AF XY: 0.0000324 AC XY: 23AN XY: 709564
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.0000805 AC XY: 6AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.866C>G (p.T289S) alteration is located in exon 4 (coding exon 4) of the EIF5B gene. This alteration results from a C to G substitution at nucleotide position 866, causing the threonine (T) at amino acid position 289 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at